文献速递前列腺癌男科与性医学

精索静脉曲张与未治疗性腺功能减退协同增加前列腺癌风险

Varicocele and Untreated Hypogonadism Synergistically Increase Prostate Cancer Risk via Testosterone Shunt Physiology and Can Be Ameliorated With Testosterone Therapy.
PubMed 文献 · Urology · 2026-04-14

基于MarketScan数据库的匹配队列研究,纳入149848名40岁以上男性,比较精索静脉曲张与良性阴囊病变对照。睾酮治疗可能减轻此效应。

核心结论

  • 精索静脉曲张可放大未治疗性腺功能减退相关的前列腺癌风险。
  • 睾酮治疗及可能的精索静脉结扎术可减轻该效应。

研究设计与样本

  • 使用Merative MarketScan数据库的匹配队列研究。
  • 纳入149848名40岁以上男性,其中精索静脉曲张75673例,良性阴囊病变对照74175例。
  • 按年龄和随访间隔匹配,采用Cox比例风险模型调整年龄、肥胖、农村性、家族史、性腺功能减退状态、睾酮治疗和精索静脉曲张状态。

临床怎么用

  • 对精索静脉曲张合并性腺功能减退的男性,应重视前列腺癌风险评估。
  • 睾酮治疗可能降低该人群的前列腺癌风险,但需结合个体情况决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether varicocele modifies the relationship between hypogonadism and incident prostate cancer. Venous shunting of testosterone-enriched blood from the testicle to the dorsal venous complex occurs in ∼20% of men and has been linked to prostate cancer progression. Although hypogonadism has been inconsistently associated with prostate cancer risk, the influence of varicocele remains unexplored. MATERIALS AND METHODS: Using the Merative MarketScan database, we identified men >40 years with varicocele and matched them by age and follow-up interval to 2 cohorts as follows: (1) a general population cohort and (2) men with benign scrotal pathology associated with urological assessment. Time to prostate cancer was assessed using Cox proportional hazards models adjusted for age, obesity, rurality, family history, hypogonadism status, testosterone therapy, and varicocele status. An interaction term between varicocele and hypogonadism was included. RESULTS: Among 149,848 men (75,673 varicocele and 74,175 scrotal pathology controls), varicocele was associated with a higher incidence of prostate cancer (4.4 vs 3.8%, P<.01) and hypogonadism (13.3 vs 11.2%, P<.01). In adjusted models, varicocele alone was not associated with prostate cancer risk (HR: 1.04, P = .18), whereas untreated hypogonadism was associated with a modest but statistically signifiant increase in incident prostate cancer risk (HR: 1.27, P<.01). Men with both varicocele and untreated hypogonadism experienced the highest hazard of incident prostate cancer (HR: 1.31, P<.001). CONCLUSION: Varicocele amplifies the risk of prostate cancer associated with untreated hypogonadism. Testosterone therapy and possibly varicocelectomy mitigate this effect, supporting the notion that venous testosterone shunting to the prostate occurs in a subset of men.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Naelitz BD, Siva J, Vallabhaneni S, et al. Varicocele and Untreated Hypogonadism Synergistically Increase Prostate Cancer Risk via Testosterone Shunt Physiology and Can Be Ameliorated With Testosterone Therapy. Urology. 2026. PMID: 41990882. doi:10.1016/j.urology.2026.04.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。